IFI35 and glioblastoma: Studies on glioblastoma multiforme (GBM) have also demonstrated the tumor-promoting role of IFI35, suggesting that inhibiting the expression of it could offer a promising strategy for enhancing GBM treatment (Li et al., 2024).